| 10-year outcomes after monitoring, surgery, or radiotherapy for localized prostate cancer FC Hamdy, JL Donovan, JA Lane, M Mason, C Metcalfe, P Holding, ... New England Journal of Medicine 375 (15), 1415-1424, 2016 | 2911 | 2016 |
| Patient-reported outcomes after monitoring, surgery, or radiotherapy for prostate cancer JL Donovan, FC Hamdy, JA Lane, M Mason, C Metcalfe, E Walsh, ... New England Journal of Medicine 375 (15), 1425-1437, 2016 | 1320 | 2016 |
| VEGF165b, an inhibitory splice variant of vascular endothelial growth factor, is down-regulated in renal cell carcinoma DO Bates, TG Cui, JM Doughty, M Winkler, M Sugiono, JD Shields, D Peat, ... Cancer research 62 (14), 4123-4131, 2002 | 790 | 2002 |
| VEGF165b, an inhibitory vascular endothelial growth factor splice variant: mechanism of action, in vivo effect on angiogenesis and endogenous protein expression J Woolard, WY Wang, HS Bevan, Y Qiu, L Morbidelli, RO Pritchard-Jones, ... Cancer research 64 (21), 7822-7835, 2004 | 644 | 2004 |
| Prostate testing for cancer and treatment (ProtecT) feasibility study J Donovan, F Hamdy, D Neal, T Peters, S Oliver, L Brindle, D Jewell, ... Core Research on belhalf of the NCCHTA 7, 1-88, 2003 | 359 | 2003 |
| Competition amongst Eph receptors regulates contact inhibition of locomotion and invasiveness in prostate cancer cells JW Astin, J Batson, S Kadir, J Charlet, RA Persad, D Gillatt, JD Oxley, ... Nature cell biology 12 (12), 1194-1204, 2010 | 263 | 2010 |
| Diagnosis, management and screening of early localised prostate cancer S Selley, J Donovan, A Faulkner, J Coast, D Gillatt Database of Abstracts of Reviews of Effects (DARE): Quality-assessed Reviews …, 1997 | 243 | 1997 |
| Introduction of an enhanced recovery protocol for radical cystectomy N Arumainayagam, J McGrath, KP Jefferson, DA Gillatt BJU international 101 (6), 698-701, 2008 | 241 | 2008 |
| The risk of prostate cancer amongst black men in the United Kingdom: the PROCESS cohort study Y Ben-Shlomo, S Evans, F Ibrahim, B Patel, K Anson, F Chinegwundoh, ... European urology 53 (1), 99-105, 2008 | 240 | 2008 |
| National survey of the incidence of cervical spine injury and approach to cervical spine clearance in US trauma centers MD Grossman, PM Reilly, T Gillett, D Gillett Journal of Trauma and Acute Care Surgery 47 (4), 684, 1999 | 231 | 1999 |
| The prevalence and natural history of urinary symptoms among recreational ketamine users. AR Winstock, L Mitcheson, DA Gillatt, AM Cottrell BJU international 110 (11), 2012 | 224 | 2012 |
| Functional evidence that vascular endothelial growth factor may act as an autocrine factor on human podocytes RR Foster, R Hole, K Anderson, SC Satchell, RJ Coward, PW Mathieson, ... American Journal of Physiology-Renal Physiology 284 (6), F1263-F1273, 2003 | 222 | 2003 |
| Fifteen-year outcomes after monitoring, surgery, or radiotherapy for prostate cancer FC Hamdy, JL Donovan, JA Lane, C Metcalfe, M Davis, EL Turner, ... New England Journal of Medicine 388 (17), 1547-1558, 2023 | 216 | 2023 |
| A systematic review of the role of imaging before salvage radiotherapy for post-prostatectomy biochemical recurrence MJ Beresford, D Gillatt, RJ Benson, T Ajithkumar Clinical oncology 22 (1), 46-55, 2010 | 196 | 2010 |
| The endogenous anti-angiogenic VEGF isoform, VEGF165b inhibits human tumour growth in mice ES Rennel, E Waine, H Guan, Y Schüler, W Leenders, J Woolard, ... British journal of cancer 98 (7), 1250-1257, 2008 | 177 | 2008 |
| Development of a complex intervention improved randomization and informed consent in a randomized controlled trial JL Donovan, JA Lane, TJ Peters, L Brindle, E Salter, D Gillatt, P Powell, ... Journal of clinical epidemiology 62 (1), 29-36, 2009 | 167 | 2009 |
| Are diet–prostate cancer associations mediated by the IGF axis? A cross-sectional analysis of diet, IGF-1 and IGFBP-3 in healthy middle-aged men D Gunnell, SE Oliver, TJ Peters, JL Donovan, R Persad, M Maynard, ... British journal of cancer 88 (11), 1682-1686, 2003 | 163 | 2003 |
| Serine–arginine protein kinase 1 (SRPK1) inhibition as a potential novel targeted therapeutic strategy in prostate cancer A Mavrou, K Brakspear, M Hamdollah-Zadeh, G Damodaran, ... Oncogene 34 (33), 4311-4319, 2015 | 152 | 2015 |
| Prevalence and impact of incontinence and impotence following total prostatectomy assessed anonymously by the ICS-male questionnaire TS Bates, MPJ Wright, DA Gillatt European urology 33 (2), 165-169, 1998 | 150 | 1998 |
| Ten-year mortality, disease progression, and treatment-related side effects in men with localised prostate cancer from the ProtecT randomised controlled trial according to … DE Neal, C Metcalfe, JL Donovan, JA Lane, M Davis, GJ Young, ... European urology 77 (3), 320-330, 2020 | 138 | 2020 |
